ETH Zürich, Prof. Dr. Sabine Werner und das SKINTEGRITY.CH Konsortium: Symposium zum Thema Tumor-Mikroumgebung
The tumor microenvironment (TME) refers to the complex ecosystem surrounding cancer cells, composed of immune cells, fibroblasts, nerve cells, blood vessels, signaling molecules, and the extracellular matrix. Interactions within this environment play a critical role in tumor growth, progression, and response to therapy. For instance, cancer-associated fibroblasts and immune cells can either suppress or promote tumor development depending on their activation state.
Understanding the TME is essential for developing more effective cancer treatments. By targeting not only the tumor cells but also their supportive environment, researchers aim to disrupt tumor-promoting signals and enhance anti-tumor immunity, ultimately improving patient outcomes.
Since 1975, the Wilhelm Sander-Stiftung has supported medical research, in particular in the field of cancer research. To celebrate the 50th anniversary of the foundation, it has taken up the joint initiative with the SKINTEGRITY.CH consortium, to organize an event that puts some of the cutting-edge research on the tumor microenvironment in the spotlight.
It is thus with immense pleasure that we announce a mini-symposium of one afternoon, on Friday, February 6, 2026, in which some of the leading researchers in this field will share their latest findings. The detailed program for the afternoon is given below. The event will take place in the „H33 Auditorium“ on the Hönggerberg Campus of the ETH Zurich (HPM Building, H Floor), at the Otto‑Stern‑Weg 3.
Please note: Registration will open in December 2025.
